This Week in Nature

In Nature this week, Stanford University scientists led by 2012 Nobel Laureate Brian Kobilka publish the structure of a human G-protein-coupled receptor bound to a drug. Specifically, they showed the crystal structure of the coagulation-mediating human protease-activated receptor 1 associated with vorapaxar, a PAR1 antagonist under clinical development for the prevention of cardiovascular events in patients with a history of heart attacks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.